| Value | ₹4.91 Cr |
|---|
BSE filing, NSE: LOTUSDEV. Summary written from the filing by ALFA Finder's alert engine.
Sri Lotus Developers and Realty Ltd: key numbers
- Share price
- ₹245.98
- Market cap
- ₹12,022 Cr
- Revenue (annual)
- ₹769.0 Cr
- Net profit (annual)
- ₹237.1 Cr
- P/E (TTM)
- 41.0×Sector 34.4×
- Promoter holding
- 79.87%-2.00% QoQ
- FII holding
- 4.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sri Lotus Developers and Realty Ltd
All →Sri Lotus Developers and Realty Earnings Call Transcript: Key Takeaways
Lotus records explosive growth in luxury residential and commercial redevelopment, leveraging a net debt-free balance sheet.
- Call
- Guides 60% growth
Sri Lotus Developers and Realty Other Announcement
Sri Lotus Developers submitted its Monitoring Agency Report for the quarter ended September 30, 2026, confirming the utilization status of IPO proceeds as per SEBI regulations.
Sri Lotus Developers and Realty Results Update
Sri Lotus Developers reported strong Q2 FY27 performance, with pre-sales rising 83% to ₹470 crore and profit after tax growing 91% to ₹89 crore.
Sri Lotus Developers and Realty Board Meeting Date
Sri Lotus Developers intimated BSE and NSE that its Board will meet on 15 Oct 2026 to consider Q1/H1 FY27 results. No figures or decisions are reported in this advance notice.
Sri Lotus Developers and Realty Other Announcement
Sri Lotus Developers and Realty Ltd submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Sri Lotus Developers and Realty Management Change
Sri Lotus Developers and Realty Limited appointed Mr. Paarth Deepak Chheda as Executive Director for five years. Mrs. Roopa Anand Pandit resigned as Non-Executive Director effective October 1, 2026.
- Execution
- 5 years
Other capital structure change announcements
All →Piramal Pharma Capital Structure Change
HDFC Mutual Fund schemes reduced their Piramal Pharma stake by 2.027% via open market sale on 28 October 2026. Holding fell from 7.015% to 4.988%.
Rane Holdings Capital Structure Change
Rane Holdings took up 5,15,954 rights shares in its 49%-owned JV, ZF LIFETEC Rane Automotive. No consideration is disclosed, and its stake stays at 49%.
Automobile Corporation Of Goa Capital Structure Change
Automobile Corporation of Goa filed its buyback letter of offer for 1,44,639 shares at Rs 2,005 each. Up to Rs 29.00 Crore tender buyback opens November 3.
- Value
- ₹29.00 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme closed its buyback after purchasing 2,410,906 shares for ₹69.70 Crore. Closure took effect October 30, 2026, ahead of the scheduled period.
- Value
- ₹69.70 Cr
- Execution
- August 14, 2026 to October 30, 2026
Medi Assist Healthcare Services Capital Structure Change
Medi Assist Healthcare's board approved a tender-offer buyback of up to 11,59,199 shares at Rs 425 each, capped at Rs 49.27 Crore. The record date is 20 November 2026, and promoters will not participate.
- Value
- ₹49.27 Cr
KS Smart Technologies Capital Structure Change
KS Smart Technologies called an extraordinary general meeting on 25-Nov-2026 to approve increasing its authorised share capital. The resolution also alters the MoA and AoA clauses.